散结镇痛胶囊联合曼月乐治疗子宫腺肌病疗效观察

散结镇痛胶囊联合曼月乐治疗子宫腺肌病疗效观察
马幼菊;马晓莉
【期刊名称】《医学研究与教育》
【年(卷),期】2014(000)004
【摘要】Objective To explore the clinical effects of Sanjie Snalgesic capsule and mirena in the treatment of uterine adenomyosis. Methods The patients with uterine adenomyosis in our hospital were collected at random,and they were treated with mifepristone, mirena, Sanjie Snalgesic capsule and mirena. The degree of dysmenorrheal, uterine volume, HGB, serum CA125 level of the three groups before and after 3 months treatment were observed. Results After 3 months treatment, the symptoms of three groups were improved effectively. All patients were amenorrhea.The degree of dysmenorrheal, uterine volume, serum CA125 level of the mirena, Sanjie Snalgesic capsule and mirena groups were signiifcantly lower than those in the mifepristone group, otherwise the level of HGB was significantly higher. The degree of dysmenorrheal, uterine volume, serum CA125 level of the Sanjie Snalgesic capsule and mirena group was signiifcantly lower than those in the mirena group. Conclusion The Sanjie Snalgesic capsule and mirena has a good synergy effect in treating uterine adenomyosis, it can improve the clinical effects, reduce the adverse reaction of using myopathy, it is worthy of clinical popularization.%目的：探讨散结镇痛胶囊联合曼月乐治疗子宫腺肌病的临床效果。

方法收集医院收
治的子宫腺肌病患者为研究对象，根据入院时间随机分为米非司酮组、曼月乐组、曼月乐联合散结镇痛胶囊组。

观察3组患者治疗前和治疗后3个月患者痛经程度、子宫体积、血红蛋白、血清CA125水平，并观察不良反应发生情况。

结果治疗后
3组患者各项症状均有改善。

其中所有患者治疗后均闭经；曼月乐组和曼月乐联合散结镇痛胶囊组痛经评分、子宫体积、CA125下降程度均低于米非司酮组，血红
蛋白升高程度高于米非司酮组，差别有统计学意义（P<0.05）；曼月乐联合散结
镇痛胶囊组痛经评分、子宫体积、CA125下降程度均低于曼月乐组，差异有统计
学意义（P<0.05）。

结论散结镇痛胶囊联合曼月乐治疗子宫腺肌病能提高疗效，
降低不良反应，具有较好的协同作用，值得临床推广应用。

【总页数】4页(P16-19)
【作者】马幼菊;马晓莉
【作者单位】河北大学附属医院妇产科，河北保定 071000;河北大学中医学院，
河北保定 071000
【正文语种】中文
【中图分类】R71
【相关文献】
1.曼月乐联合散结镇痛胶囊对子宫腺肌病患者子宫体积、痛经及月经的影响 [J],
徐秋霞;赵相军
2.散结镇痛胶囊联合曼月乐治疗子宫腺肌病临床效果及安全性评价 [J], 邵永红;王芸
3.散结镇痛胶囊联合曼月乐治疗子宫腺肌病的Meta分析 [J], 古子娟;卢如玲;袁烁;邓高丕
4.曼月乐环联合中药散结镇痛胶囊治疗对子宫腺肌病患者性激素的影响 [J], 粟海
艳
5.单纯宫内放置曼月乐与诺雷得联合曼月乐治疗子宫腺肌病的疗效观察与分析 [J], 黄杰玲
因版权原因，仅展示原文概要，查看原文内容请购买。